Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT03692767. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02776891. IPD Sharing: NO. Countries: 0. Publications: 0.
Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00336206. IPD Sharing: Not stated. Countries: 0. Publications: 0.
INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06209671. IPD Sharing: NO. Countries: 0. Publications: 0.
A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies
ClinicalTrials.gov study NCT05263739. IPD Sharing: NO. Countries: 0. Publications: 0.
CD19 CAR T Cells in Children and Adults With Relapsed or Refractory CD19 Positive B Cell Malignancies
ClinicalTrials.gov study NCT04943016. IPD Sharing: NO. Countries: 0. Publications: 0.
The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study
ClinicalTrials.gov study NCT05169203. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue
ClinicalTrials.gov study NCT01044004. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia
ClinicalTrials.gov study NCT04100187. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00301301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1
ClinicalTrials.gov study NCT06777264. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment
ClinicalTrials.gov study NCT00939328. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase I/II Study of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04856137. IPD Sharing: NO. Countries: 0. Publications: 0.
Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00834951. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01553162. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT03105596. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
ClinicalTrials.gov study NCT00224354. IPD Sharing: Not stated. Countries: 0. Publications: 0.
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00324831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma
ClinicalTrials.gov study NCT07198373. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05091541. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.